• Je něco špatně v tomto záznamu ?

Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats-pharmacokinetics, effects on behaviour and thermoregulation

K. Syrová, K. Šíchová, H. Danda, E. Lhotková, P. Jorratt, N. Pinterová-Leca, Č. Vejmola, L. Olejníková-Ladislavová, K. Hájková, M. Kuchař, J. Horáček, T. Páleníček

. 2023 ; 14 (-) : 1120419. [pub] 20230309

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002718

Introduction:N-2-methoxy-benzylated ("NBOMe") analogues of phenethylamine are a group of new psychoactive substances (NPS) with reported strong psychedelic effects in sub-milligram doses linked to a number of severe intoxications, including fatal ones. In our present work, we provide a detailed investigation of pharmacokinetics and acute behavioural effects of 2C-B-Fly-NBOMe (2-(8-bromo-2,3,6,7-tetrahydrobenzo [1,2-b:4,5-b']difuran-4-yl)-N-[(2-methoxybenzyl]ethan-1-amine), an analogue of popular psychedelic entactogen 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). Methods: All experiments were conducted on adult male Wistar rats. Pharmacokinetic parameters of 2C-B-Fly-NBOMe (1 mg/kg subcutaneously; s. c.) in blood serum and brain tissue were analysed over 24 h using liquid chromatography-mass spectrometry (LC/MS). For examination of behavioural parameters in open field test (OFT) and prepulse inhibition (PPI) of acoustic startle reaction (ASR), 2C-B-Fly-NBOMe (0.2, 1 and 5 mg/kg s. c.) was administered in two temporal onsets: 15 and 60 min after administration. Thermoregulatory changes were evaluated in individually and group-housed animals over 8 h following the highest dose used in behavioural experiments (5 mg/kg s. c.). Results: Peak drug concentrations were detected 30 and 60 min after the drug application in serum (28 ng/ml) and brain tissue (171 ng/g), respectively. The parental compound was still present in the brain 8 h after administration. Locomotor activity was dose-dependently reduced by the drug in both temporal testing onsets. ASR was also strongly disrupted in both temporal onsets, drug's effect on PPI was weaker. 2C-B-Fly-NBOMe did not cause any significant thermoregulatory changes. Discussion: Our results suggest that 2C-B-Fly-NBOMe penetrates animal brain tissue in a relatively slow manner, induces significant inhibitory effects on motor performance, and attenuates sensorimotor gating. Its overall profile is similar to closely related analogue 2C-B and other NBOMe substances.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002718
003      
CZ-PrNML
005      
20231213104545.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphar.2023.1120419 $2 doi
035    __
$a (PubMed)36969854
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Syrová, Kateřina $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
245    10
$a Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats-pharmacokinetics, effects on behaviour and thermoregulation / $c K. Syrová, K. Šíchová, H. Danda, E. Lhotková, P. Jorratt, N. Pinterová-Leca, Č. Vejmola, L. Olejníková-Ladislavová, K. Hájková, M. Kuchař, J. Horáček, T. Páleníček
520    9_
$a Introduction:N-2-methoxy-benzylated ("NBOMe") analogues of phenethylamine are a group of new psychoactive substances (NPS) with reported strong psychedelic effects in sub-milligram doses linked to a number of severe intoxications, including fatal ones. In our present work, we provide a detailed investigation of pharmacokinetics and acute behavioural effects of 2C-B-Fly-NBOMe (2-(8-bromo-2,3,6,7-tetrahydrobenzo [1,2-b:4,5-b']difuran-4-yl)-N-[(2-methoxybenzyl]ethan-1-amine), an analogue of popular psychedelic entactogen 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). Methods: All experiments were conducted on adult male Wistar rats. Pharmacokinetic parameters of 2C-B-Fly-NBOMe (1 mg/kg subcutaneously; s. c.) in blood serum and brain tissue were analysed over 24 h using liquid chromatography-mass spectrometry (LC/MS). For examination of behavioural parameters in open field test (OFT) and prepulse inhibition (PPI) of acoustic startle reaction (ASR), 2C-B-Fly-NBOMe (0.2, 1 and 5 mg/kg s. c.) was administered in two temporal onsets: 15 and 60 min after administration. Thermoregulatory changes were evaluated in individually and group-housed animals over 8 h following the highest dose used in behavioural experiments (5 mg/kg s. c.). Results: Peak drug concentrations were detected 30 and 60 min after the drug application in serum (28 ng/ml) and brain tissue (171 ng/g), respectively. The parental compound was still present in the brain 8 h after administration. Locomotor activity was dose-dependently reduced by the drug in both temporal testing onsets. ASR was also strongly disrupted in both temporal onsets, drug's effect on PPI was weaker. 2C-B-Fly-NBOMe did not cause any significant thermoregulatory changes. Discussion: Our results suggest that 2C-B-Fly-NBOMe penetrates animal brain tissue in a relatively slow manner, induces significant inhibitory effects on motor performance, and attenuates sensorimotor gating. Its overall profile is similar to closely related analogue 2C-B and other NBOMe substances.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šíchová, Klára $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia
700    1_
$a Danda, Hynek, $d 1988- $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia $7 xx0311507
700    1_
$a Lhotková, Eva $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia
700    1_
$a Jorratt, Pascal $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Pinterová-Leca, Nikola $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Vejmola, Čestmír $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Olejníková-Ladislavová, Lucie $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Hájková, Kateřina $u Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czechia
700    1_
$a Kuchař, Martin $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Forensic Laboratory of Biologically Active Compounds, Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Czechia
700    1_
$a Horáček, Jiří $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Páleníček, Tomáš $u Psychedelics Research Centre, National Institute of Mental Health, Prague, Czechia $u Third Faculty of Medicine, Charles University, Prague, Czechia
773    0_
$w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 14, č. - (2023), s. 1120419
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36969854 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20231213104541 $b ABA008
999    __
$a ok $b bmc $g 1922641 $s 1188925
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1120419 $e 20230309 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
LZP    __
$a Pubmed-20230413

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace